Tuesday, August 16, 2022

561.316.3330

Dr. Alex van Belkum Appointed BaseClear Chief Scientific Officer

Effective December 1, 2021

Latest Posts

Lytix Biopharma Announced Data from its ATLAS-IT-04 Trial

The ATLAS-IT-04 trial was an open-label, exploratory, Phase II trial assessing the effect of LTX-315 when used in combination with ACT in patients with metastatic STS. ACT with tumor infiltrating lymphocytes (TILs) is a potent treatment that can induce complete and durable tumor regression as documented in patients with melanoma. The use of ACT with TILs for patients with advanced STS has not previously been reported.

Telehealth Post Pandemic Concerns By Mark Kestner Chief Innovation Officer for MediGuru

The expression “desperate times call for desperate measures” aptly explains developments in the field of telehealth during the COVID-19 pandemic. In order to serve those forced to stay in place by the pandemic, healthcare regulators made a number of concessions that loosened controls related to patient privacy and data security in an effort to boost accessibility. In essence, telehealth practices that were a concern prior to Covid were, for the sake of serving patients, deemed acceptable.

Alleviating Transportation Woes: Technology is likely a Silver Bullet, for the Transportation Industry and Beyond By: PJ Piper, Founder & CEO, Far UV Technologies

March of 2020 was a tipping point: The sudden and surreal realization of just how perilous the human journey can be, hanging by the thinnest of threads. While the world tried to understand what the Covid-19 pandemic meant for the future, billions of people immediately learned how easily dangerous invisible pathogens could upend life, literally on a dime.

Kymanox Announces First Kymanox Executive Advisor: Fran DeGrazio

Fran DeGrazio has over 35 years of experience in technical product development, quality, regulatory, marketing, and business strategy, serving most recently as the Chief Scientific Officer at West Pharmaceutical Services.

Alex Van Belkum is a highly cited molecular microbiologist with extensive experience in molecular- and culture-based diagnostics, antimicrobial resistance testing and clinical microbiology. He will lead BaseClear’s science and innovation arm together with Innovation Manager Walter Pirovano and a team of PhD-level Product Managers.

“We are extremely pleased to announce that Alex van Belkum is joining the BaseClear team. He brings significant microbiological and innovation experience that will further enhance our ability to offer clients and partners state-of-the-art microbial genomics solutions,” says Bas Reichert, BaseClear CEO. “His experience and expertise will be invaluable for our further growth in areas such as human health, personal care and animal nutrition.”

Alex van Belkum is looking forward to contributing to BaseClear’s growth strategy: “The combination of Next Generation Sequencing technologies, culturomics and microbiome research has huge potential for the future. There are great opportunities for BaseClear to develop new and innovative solutions in areas such as human health, animal health and biomarker discovery. I’ll be working together with a strong team of experienced and highly talented scientists within Innovation and Product Management and look forward to the dynamic environment that BaseClear offers,” explains Alex van Belkum.

Alex van Belkum has many years of working experience in both industry and academia. He has worked for bioMérieux for over a decade, where he has held a number of scientific leadership roles including R&D director, Corporate Vice President Microbiology, CSO, and Scientific Director of the Data Analytics department. Prior to his work at bioMérieux, he was a staff member of the Institute of Clinical Microbiology and Antimicrobial Therapy, Faculty of Medicine and Health Sciences, Erasmus University Rotterdam. He holds a double PhD in both biochemistry and molecular microbiology and is a former Professor of Molecular Microbiology at the Erasmus University Medical Center.

Latest Posts

Learn More

spot_img

Subscribe

spot_img

Our Sister Publication

Medical Device News Magazine